MetLife Investment Management’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-79,823
Closed -$117K 2764
2025
Q1
$117K Buy
79,823
+41,803
+110% +$61K ﹤0.01% 2457
2024
Q4
$81K Sell
38,020
-15,127
-28% -$32.2K ﹤0.01% 2688
2024
Q3
$149K Sell
53,147
-5,993
-10% -$16.8K ﹤0.01% 2438
2024
Q2
$138K Buy
59,140
+10,140
+21% +$23.6K ﹤0.01% 2453
2024
Q1
$219K Buy
49,000
+6,982
+17% +$31.2K ﹤0.01% 2153
2023
Q4
$135K Hold
42,018
﹤0.01% 2456
2023
Q3
$133K Hold
42,018
﹤0.01% 2434
2023
Q2
$209K Hold
42,018
﹤0.01% 2252
2023
Q1
$208K Hold
42,018
﹤0.01% 2198
2022
Q4
$264K Hold
42,018
﹤0.01% 2070
2022
Q3
$454K Buy
42,018
+1,668
+4% +$18K ﹤0.01% 1710
2022
Q2
$460K Buy
40,350
+4,024
+11% +$45.9K ﹤0.01% 1723
2022
Q1
$331K Buy
36,326
+13,419
+59% +$122K ﹤0.01% 2038
2021
Q4
$342K Hold
22,907
﹤0.01% 1724
2021
Q3
$589K Hold
22,907
0.01% 1439
2021
Q2
$597K Hold
22,907
0.01% 1466
2021
Q1
$809K Hold
22,907
0.01% 1261
2020
Q4
$578K Hold
22,907
0.01% 1416
2020
Q3
$864K Buy
22,907
+1,351
+6% +$50.9K 0.01% 1101
2020
Q2
$923K Buy
21,556
+3,547
+20% +$152K 0.01% 1071
2020
Q1
$350K Hold
18,009
﹤0.01% 1408
2019
Q4
$468K Hold
18,009
﹤0.01% 1505
2019
Q3
$491K Hold
18,009
0.01% 1432
2019
Q2
$484K Buy
18,009
+5,373
+43% +$144K 0.01% 1497
2019
Q1
$365K Hold
12,636
﹤0.01% 1639
2018
Q4
$340K Buy
+12,636
New +$340K ﹤0.01% 1600